NCT06999278View on ClinicalTrials.gov

LIGHT Trial: Levothyroxine for Gestational Hypothyroidism in Recurrent Pregnancy Loss

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

May 31, 2027

Conditions
Abortion, Habitual
Interventions
DRUG

Levothyroxin

Levothyroxin 50ug/d from randomization until delivery

DRUG

Placebo

Placebo to levothyroxin

Trial Locations (2)

310006

Zhejiang Women's Hospital, Hangzhou

310014

Zhejiang People's Hospital, Hangzhou

All Listed Sponsors
collaborator

Zhejiang Provincial People's Hospital

OTHER

lead

Women's Hospital School Of Medicine Zhejiang University

OTHER